Wockhardt Ltd
Nikhil Kela is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Manager at Wockhardt Ltd. since May 2023. Prior experience includes roles at Biocon from July 2014 to April 2023, where Nikhil held titles including Deputy Manager, Assistant Manager, and Principal Scientist, specializing in microbial and mammalian upstream process development. Nikhil also worked as a Senior Research Scientist within the Biocon Biologics group, focusing on cell banking, biological endotoxin analysis, and bio-analytical method development. Nikhil holds an M.Tech in Pharmaceutical Sciences from the National Institute of Pharmaceutical Education and Research and a Bachelor of Pharmacy from MGV, Pune University.
This person is not in the org chart
This person is not in any offices
Wockhardt Ltd
1 followers
Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid Otic Solution, Amlodipine Besylate Tablets, Adenosine Injection, Amoxicillin and Clavulanate Potassium for Oral Suspension, Azithromycin Tablets, Aciclovir Powder for Injection, Alendronic Acid, Amitriptyline, Clarithromycin, Entacapone Tablet and Flucloxacillin Injection. It operates a chain of approximately 10 super specialty hospitals, which offer treatment and care facilities in cardiology, neurosurgery, orthopedics, critical care, oncology, nephrology, urology and others. It has over 10 manufacturing plants located in India, the United Kingdom, Ireland and the United States. The Company has approximately three research centers globally.